A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis area.
Adolescent
Adult
Aged
Asymptomatic Infections
/ epidemiology
COVID-19
/ epidemiology
COVID-19 Nucleic Acid Testing
/ statistics & numerical data
Cities
/ epidemiology
Cough
/ epidemiology
Cross-Sectional Studies
Female
Fever
/ epidemiology
Humans
Indiana
/ epidemiology
Male
Middle Aged
Nasopharynx
/ virology
Prevalence
Public Health
/ statistics & numerical data
Young Adult
coronavirus
epidemiology
pandemic
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
19
05
2020
accepted:
13
06
2020
pubmed:
17
6
2020
medline:
29
12
2020
entrez:
17
6
2020
Statut:
ppublish
Résumé
The Asymptomatic novel CORonavirus iNfection (ACORN) study was designed to investigate the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the asymptomatic adult population of the Indianapolis metropolitan area, to follow individuals testing positive for the development of symptoms, and to understand duration of positive test results. ACORN is a cross-sectional community-based observational study of adult residents presenting asymptomatic for COVID-like illness, defined as the self-reported absence of the following three symptoms in the last 7 days: fever (≥100°F), new-onset or worsening cough, and new-onset or worsening shortness of breath. SARS-CoV-2 infection was determined by real-time reverse transcription-polymerase chain reaction in nasopharyngeal swab samples. SARS-CoV-2 infection prevalence was expressed as a point estimate with 95% confidence interval (CI). Test results are reported for 2953 participants who enrolled and underwent nasopharyngeal swab testing between 7 April 2020 and 16 May 2020. Among tested participants, 91 (3.1%; 95% CI: 2.5%-3.7%) were positive for SARS-CoV-2. Overall, baseline characteristics, medical history, and infection risk factors were comparable between SARS-CoV-2 positive and negative participants. Within the ongoing 14-day follow-up period for positive participants, 58 (71.6%) of 81 assessed participants remained asymptomatic while others (n = 23, 28.4%) reported one or more symptoms. Indiana had "Stay-at-Home" orders in place during nearly the entire test period reported here, yet 3.1% of asymptomatic participants tested positive for SARS-CoV-2. These results indicate screening questions had limited predictive utility for testing in an asymptomatic population and suggest broader testing strategies are needed. Importantly, these findings underscore that more research is needed to understand the viral transmission and the role asymptomatic and presymptomatic individuals play in this global pandemic.
Identifiants
pubmed: 32543722
doi: 10.1002/jmv.26182
pmc: PMC7323176
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2874-2879Subventions
Organisme : Eli Lilly and Company
Pays : International
Informations de copyright
© 2020 The Authors. Journal of Medical Virology Published by Wiley Periodicals LLC.
Références
N Engl J Med. 2020 Mar 26;382(13):1194-1196
pubmed: 32074416
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
J Med Virol. 2020 Nov;92(11):2874-2879
pubmed: 32543722
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930